Bon Natural Life Limited

Bon Natural Life Limited

BON
Bon Natural Life LimitedUS flagNASDAQ Capital Market
1.24
USD
-0.02
- -
7.55MMarket Cap
Bon Natural Life Limited
BON
(NASDAQ Capital Market)

Recent

price

1.24

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
FRC
345.57
512.38
555.49
963.4
894.31
807.55
- -
- -
Revenue per Share
7.16
80.43
92.28
173.48
186.51
125.72
- -
- -
Basic EPS, GAAP
-8.54
215.35
79.61
141.03
-6.42
-36.87
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1.69
74.03
154.67
347.41
438.88
511.66
- -
- -
Book Value per Share
140.98
222.66
331.77
987.18
888.87
963.28
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
11
16
18
25
30
30
24
19
Sales/Revenue/Turnover
6.21
20.22
21.02
22.95
26.44
20.19
8.12
-8.49
Operating Margin (%)
- -
- -
- -
- -
- -
1
1
1
Depreciation Expense
- -
3
3
5
6
5
- -
-2
Net Income, GAAP
44.93
14.29
15.22
15.12
16.74
17.99
49.05
- -
Effective Tax Rate (%)
2.07
15.7
16.61
18.01
20.86
15.57
1.67
-10.68
Profit Margin (%)
5
-2
-1
9
8
15
23
19
Working Capital
3
1
2
2
1
1
1
1
LT Debt
5
7
11
27
30
36
44
58
Total Equity
- -
21.87
18.08
17.76
18.39
12.3
2.01
- -
Return on Invested Capital (%)
- -
37.11
32.04
40.49
39.26
22.01
2.43
- -
Return on Capital (%)
- -
212.56
81.34
64.36
52.26
27.54
2.13
-11.23
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
45.55%
30.77%
Free Cash Flow
- -
181.84%
-28.98%
Net Income, GAAP
- -
-126.22%
-600.98%
Sales/Revenue/Turnover
- -
3%
-21.7%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
30
2024
- -
- -
- -
- -
24
2025
- -
- -
- -
- -
19

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
125.72
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Bon Natural Life Limited is engaged in the exploration, production, and distribution of specialized active ingredients derived from natural plant sources, catering to markets both in the People's Republic of China and internationally. The company provides essential components for personal care, including botanical fragrance compounds for various perfume and scent manufacturers. Additionally, it develops natural health supplements such as powdered drink mixes and bioactive food ingredients, which are largely incorporated into food products and nutritional formulas. The firm also features its own branded health solutions, notably in areas like weight management and digestive wellness. Expanding its capabilities, Bon Natural Life recently established an AI-driven research and development division for drug discovery, leading to breakthroughs such as identifying promising weight-managing compounds from tea. These diverse products are predominantly supplied to manufacturer clients within the functional food, personal care, cosmetic, and pharmaceutical industries. Founded in 2006, the company's operational base is located in Xi'an, People's Republic of China.

Company News

APIChat
  • BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives

  • Analyzing Sow Good (NASDAQ:SOWG) & Bon Natural Life (NASDAQ:BON)

  • Head-To-Head Contrast: Bon Natural Life (NASDAQ:BON) vs. Pigeon (OTCMKTS:PGENY)

  • BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market

  • BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing

  • Foxx Development (NASDAQ:FOXX) & Bon Natural Life (NASDAQ:BON) Head-To-Head Contrast

  • Bon Natural Life Limited (NASDAQ:BON) Sees Significant Increase in Short Interest

  • Lifetime Brands (NASDAQ:LCUT) & Bon Natural Life (NASDAQ:BON) Head-To-Head Review

  • BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan

  • BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan

  • BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products

  • BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform

  • BON Announces Reciept of Nasdaq Compliance Letter

  • BON Launches AI-Powered New Drug Research and Development

  • BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd

  • BON Announces Nasdaq Compliance

  • Bon Announces Breakthrough Order for $16 Million Gut-Health Products

  • Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.

  • BON Announces Share Repurchase Program for up to US$1.0 Million

  • BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade